Recent Insider Transactions - Atos Therapeutics (NASDAQ: ATOS)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ ATOS Atos Therapeutics

QUAY STEVEN C / director, officer: President & CEO

05/21/2025

Buy

$0.88

11,239

$10K

13,898

NASDAQ ATOS Atos Therapeutics

Finn Jonathan / director

05/15/2025

Buy

$0.99

125,000

$124K

125,000

NASDAQ ATOS Atos Therapeutics

Chen Shu-Chih / director

05/15/2025

Buy

$0.99

125,000

$124K

125,000

NASDAQ ATOS Atos Therapeutics

QUAY STEVEN C / director, officer: President & CEO

05/15/2025

Buy

$0.99

1.37M

$1.352M

1.37M

NASDAQ ATOS Atos Therapeutics

Rees Heather / officer: Chief Financial Officer

05/15/2025

Buy

$0.99

543,785

$538K

543,785

NASDAQ ATOS Atos Therapeutics

Galli Stephen J / director

05/15/2025

Buy

$0.99

125,000

$124K

125,000

NASDAQ ATOS Atos Therapeutics

Remmel H. Lawrence / director

05/15/2025

Buy

$0.99

125,000

$124K

125,000

NASDAQ ATOS Atos Therapeutics

Cigler Tessa / director

05/15/2025

Buy

$0.99

125,000

$124K

125,000

NASDAQ ATOS Atos Therapeutics

Steinhart Richard I / director

05/15/2025

Buy

$0.99

125,000

$124K

125,000